ICL Group Ltd. Files December 2025 6-K Report
Ticker: ICL · Form: 6-K · Filed: Dec 4, 2025 · CIK: 941221
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
ICL Group Ltd. filed its December 2025 6-K, standard foreign issuer report.
AI Summary
ICL Group Ltd. filed a Form 6-K report on December 4, 2025, for the month of December 2025. The report is a routine filing for a foreign private issuer and is incorporated by reference into their registration statements. The company, formerly known as Israel Chemicals Ltd., is based in Tel Aviv, Israel.
Why It Matters
This filing indicates ongoing reporting compliance for ICL Group Ltd., a significant player in the agriculture and chemicals sector, providing transparency to investors.
Risk Assessment
Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain new financial or operational information that would typically alter risk.
Key Numbers
- 20251204 — Filing Date (Date the report was filed with the SEC.)
Key Players & Entities
- ICL Group Ltd. (company) — Registrant
- Israel Chemicals Ltd. (company) — Former company name
- 001-13742 (dollar_amount) — Commission File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer makes or is required to make public in its home country.
When was ICL Group Ltd. formerly known as?
ICL Group Ltd. was formerly known as ISRAEL CHEMICALS LTD, with a date of name change on March 14, 1995.
What is the Commission File Number for ICL Group Ltd.?
The Commission File Number for ICL Group Ltd. is 001-13742.
Where is ICL Group Ltd. headquartered?
ICL Group Ltd. is headquartered in Tel Aviv, Israel, with its principal executive office located at Millennium Tower, 23 Aranha Street, P.O. Box 20245.
Does ICL Group Ltd. file annual reports under Form 20-F or 40-F?
ICL Group Ltd. files annual reports under cover of Form 20-F, as indicated by the checkmark in the filing.
Filing Stats: 1,867 words · 7 min read · ~6 pages · Grade level 19.8 · Accepted 2025-12-04 06:01:12
Filing Documents
- zk2534089.htm (6-K) — 29KB
- 0001178913-25-004004.txt ( ) — 30KB
Forward-Looking Statements
Forward-Looking Statements This report includes forward-looking information. Forward-looking statements typically use terminology such as "examines," "estimates," "possible," "may," "expects," and similar expressions. Forward-looking statements appear in this report and include, among other things, statements relating to the terms of the future concession, the legislative process of the Draft Bill and its ultimate form, as well as the potential execution by the Company of a detailed agreement with the Government of Israel. Such statements are based on assessments, forecasts, intentions and plans of the Company's management, and on information available to management as of the date of this report. Forward-looking statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied by such statements due to various factors. For example, there is no certainty that the legislative process will be completed, and if completed - whether it will include all or any of the terms referenced in the Draft Bill; there is no certainty regarding the chapters not yet included in the Draft Bill, and the final law may differ materially, both in its substance and in its effective date; nor is there any certainty that the principles agreement executed with the Government will mature into a binding agreement at all. Likewise, there is no certainty that the Company's comments on the Draft Bill, to be submitted as part of the public process, will be accepted. As a result of the foregoing, readers should not place undue reliance on the forward-looking statements included in this report, or on additional specific risks and uncertainties facing the Company, such as those described under "Risk Factors" in its Annual Report on Form 20-F published on March 13, 2025, as such risk factors may be updated from time to time in the Company's periodic reports and public filings on Form 6-K and in other reports furnished to the U.S. Securities and